Omnilink Elite™

Vascular Balloon-Expandable Stent System

Elite engineering and performance.

Strength and flexibility that provides superb results in the iliacs.

Engineering

  • Cobalt chromium multi-link technology that allows for thin struts without sacrificing strength for flexibility and vessel conformability
  • Superb accuracy with minimal impact to stent length^
  • Thin struts to minimize vessel wall injury1
  • Dual-layer balloon for a low profile system to treat difficult-to-reach lesions

Clinical Results

  • 97.0% clinically driven freedom from TLR at 9 months
  • 91.9% patency in TASC C lesions at 2 years in iliacs2*
  • 84.8% patency in TASC D lesions at 2 years in iliacs2**

High Freedom from Clinically-Driven TLR through 3 Years

Event-Free Survival through 3 Years


Significant Improvement in Walking Capacity as Measured by WIQ

WIQ Mean Score
Stent Loop


Compliance

WIQ Mean Score
STENT
DIAMETER
(mm)
INFLATION PRESSURE (atm)
11121314
6.06.026.146.236.33
7.06.947.097.217.31
8.08.068.218.358.45
9.08.768.939.089.19
10.09.9010.0710.2110.33
Stent Close-up


Stent Sizes and Specifications

STENT
DIAMETER
(mm)
STENT LENGTH (mm)NOM/RBP
(atm)
MAX
CRIMPED O.D.
(mm)
MAX POST-
DILATATION
DIAMETER
(mm)
121619293959
6.06F6F6F6F6F6F11/141.958.0
7.06F6F6F6F6F6F11/142.05
8.0------6F6F6F6F11/142.1011.0
9.0------6F6F7F7F11/142.15
10.0------7F7F7F7F11/142.30


Data on file at Abbott unless otherwise noted.

^-1.81% shortening for 8.0 mm x 38 mm size. Tests performed by and data on file at Abbott.
* Combined clinical results from BRAVISSIMO study where 66%/34% of TASC C lesions were treated with Absolute Pro™ Vascular Self-Expanding Stent System / Omnilink Elite™ Vascular Balloon-Expandable Stent System respectively.
**Combined clinical results from BRAVISSIMO study where 54%/46% of TASC D lesions were treated with Absolute Pro™ Vascular Self-Expanding Stent System / Omnilink Elite™ Vascular Balloon-Expandable Stent System respectively.
^^Omnilink Elite™ Vascular Balloon-Expandable Stent System Instructions For Use (IFU). Reference the IFU for additional information.
 

References

  1. Pache, et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. JACC 2003; 41:1283-8.
  2. Donato, G. et al. 24-Month Data from the BRAVISSIMO: A Large-Scale Prospective Registry on Iliac Stenting for TASC A & B and TASC C & D Lesions. Annals of Vascular Surgery. 2015; 29(4): 738-750.

MAT-2504137 v1.0

Important Safety Information
 

Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...